BTIS
ICPT

BB&T Investment Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

BB&T Investment Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3
Closed – – 1494
2017
Q3 		$0 Hold
3
– – ﹤0.01% 1337
2017
Q2 		$0 Hold
3
– – ﹤0.01% 1240
2017
Q1 		$0 Buy
+3
New +$350 ﹤0.01% 1125

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BB&T Investment Services's ICPT Position: Q4 2017 in Review

BB&T Investment Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2017, closing a stake of 3 shares.

BB&T Investment Services first reported a position in ICPT in Q1 2017 and held it in 3 quarters. The position peaked at $0 in Q3 2017. 168 funds tracked by Wall St. Rank hold ICPT as of Q4 2017.

  • BB&T Investment Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • BB&T Investment Services sold 3 Intercept Pharmaceuticals, Inc. shares in Q4 2017.
  • BB&T Investment Services first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 3 quarters.
  • BB&T Investment Services's Intercept Pharmaceuticals, Inc. position peaked at $0 in Q3 2017.
  • 168 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.